Clinical management of pregnant women with Wolff-Parkinson-White Syndrome: diagnosis, treatment and fetal repercussions of interventions

Authors

DOI:

https://doi.org/10.33448/rsd-v11i17.38889

Keywords:

Wolff-Parkinson-White Syndrome; Cardiovascular Diseases; Pregnant Woman; Clinical Diagnosis; Disease management.

Abstract

Objective: To gather data on the clinical management of pregnant women with Wolff-Parkinson-White Syndrome, including diagnosis, treatment and fetal repercussions of interventions, in order to recognize the best procedures and ensure a good maternal-fetal prognosis. Methodology: Integrative literature review that aims to elucidate the question posed from the PICo strategy "How is the clinical management of pregnant women with Wolff-Parkinson-White Syndrome?", based on articles selected from MEDLINE/PubMed®, BVS MS and WoS. Results: The clinical presentation may be nonspecific and particular, which requires additional tests. Thus, the electrocardiogram is essential for diagnosis and identification of underlying arrhythmias that put mother and fetus at risk. Characteristic accessory pathway findings should be considered, such as the state of ventricular preexcitation: compensatory tachycardia, decreased PR interval, increased QRS complex, delta waves in different leads, and changes in ventricular repolarization. About treatment, except in maternal-fetal hemodynamic risk, it should be postponed to second and third trimesters, being preferable non-invasive therapeutic methods with proven benefits. When drugs are needed, Adenosine, Quinidine, Ibutilide, Propafenone, Verapamil, and Ajmaline have been shown to be safe, Propranolol should be avoided, and Amiodarone and Sotalol are contraindicated. Still, an individualized alternative, for refractory cases, is radiofrequency ablation of the accessory pathway. Conclusion: Wolff-Parkinson-White Syndrome in pregnant women generates great risks and its diagnosis can be a challenge, as well as its treatment, based on antiarrhythmic drugs that are still controversial in pregnancy. The scarcity of current studies on the subject was a limiting factor for the present review.

References

Ahmad, A., Jamjute, P., & Bickerton, N. (2008). Wolff–Parkinson syndrome in pregnancy: risks and management dilemmas—a review of literature. European Clinics in Obstetrics and Gynaecology, 3(3-4), 123–126.

Avila, W. S., Alexandre, E. R. G., Castro, M. L., Lucena, A. J. G., Marques-Santos, C., Freire, C. M. V., Rossi, E. G., Campanharo, F. F., Rivera, I. R., Costa, M. E. N. C., Rivera, M. A. M., Carvalho, R. C. M., Abzaid, A., Moron, A. F., Ramos, A. I. de O., Albuquerque, C. J. da M., Feio, C. M. A., Born, D., Silva, F. B., & Nani, F. S. (2020). Posicionamento da Sociedade Brasileira de Cardiologia para Gravidez e Planejamento Familiar na Mulher Portadora de Cardiopatia – 2020. Arquivos Brasileiros de Cardiologia, 114(5), 849–942.

Botelho, L. L. R., de Almeida Cunha, C. C., & Macedo, M. (2011). O método da revisão integrativa nos estudos organizacionais. Gestão e sociedade, 5(11), 121-136.

Brizgys, R. V., & Shnider, S. M. (1984). Hyperbaric intrathecal morphine analgesia during labor in a patient with Wolff-Parkinson-White syndrome. Obstetrics and Gynecology, 64(3 Suppl), 44S46S.

Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al-Attar, N., Hindricks, G., Prendergast, B., Heidbuchel, H., Alfieri, O., Angelini, A., Atar, D., Colonna, P., Caterina, R., Sutter, J., & Goette, A. (2010). Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal, 31(19), 2369–2429.

Chauveau, S., Le Vavasseur, O., Morel, E., Dulac, A., & Chevalier, P. (2019). Flecainide is a safe and effective treatment for pre-excited atrial fibrillation rapidly conducted to the ventricle in pregnant women: a case series. European Heart Journal - Case Reports, 3(2).

Domínguez, A., Iturralde, P., Hermosillo, A. G., Colin, L., Kershenovich, S., & Garrido, L. M. (1999). Successful radiofrequency ablation of an accessory pathway during pregnancy. Pacing and Clinical Electrophysiology: PACE, 22(1 Pt 1), 131–134.

Friedmann, A. A. (2016). Taquicardias da síndrome de Wolff-Parkinson-White. Diagnóstico e tratamento, 21(4), 174-176.

Gray, M., & D’Amato, L. (2000). Medically Complex Pregnancy: A Case Report Illustrating Cnm/Md Collaborative Management. Journal of Midwifery & Women’s Health, 45(6), 552–557.

Harris, L., Gow, R. M., Kirsh, J. A., Klein, G. J., & Siu, S. C. (2005). Atrial arrhythmias and special circumstances. The Canadian Journal of Cardiology, 21 Suppl B, 51B60B.

Hebbar, A. K., & Hueston, W. J. (2002). Management of common arrhythmias: Part II. Ventricular arrhythmias and arrhythmias in special populations. American Family Physician, 65(12), 2491–2496.

Jeong, H. K., Yoon, N., Park, H. W., & Cho, J. G. (2020). Radiofrequency catheter ablation without radiation exposure in a 13th week pregnant woman with Wolff-Parkinson-White syndrome. Reviews in Cardiovascular Medicine, 21(2), 303.

Kanjwal, Y., Kosinski, D., Kanj, M., Thomas, W., & Grubb, B. (2005). Successful radiofrequency catheter ablation of left lateral accessory pathway using transseptal approach during pregnancy. Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing, 13(3), 239–242.

Katsuragi, S., Kamiya, C., Yamanaka, K., Neki, R., Miyoshi, T., Iwanaga, N., Horiuchi, C., Tanaka, H., Yoshimatsu, J., Niwa, K., & Ikeda, T. (2013). Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. American Journal of Obstetrics and Gynecology, 209(5), 452.e1-6.

Klepper, I. (1981). Cardioversion in late pregnancy. Anaesthesia, 36(6), 611–616.

Kockova, R., Kocka, V., Kiernan, T., & Fahy, G. J. (2007). Ibutilide-induced cardioversion of atrial fibrillation during pregnancy. Journal of Cardiovascular Electrophysiology, 18(5), 545–547.

Mendes, K. D. S., Silveira, R. C. de C. P., & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto - Enfermagem, 17(4), 758–764.

Munehisa, Y., Watanabe, H., Kosaka, T., Kimura, A., & Ito, H. (2007). Successful Outcome in a Pregnant Woman with Isolated Noncompaction of the Left Ventricular Myocardium. Internal Medicine, 46(6), 285–289.

Oliveira, M. D., António, H., & Reis. (2011). Síndrome Wolff-Parkinson-White. [Dissertação de Mestrado, Universidade do Porto].

Qiu, M., Lv, B., Lin, W., Ma, J., & Dong, H. (2018). Sudden cardiac death due to the Wolff–Parkinson–White syndrome. Medicine, 97(51), e13248.

Rosales, F. Mozo., Moreno, J., Bodegas, A., Melchor, J. C., LLebrez, L. Fernández., & Aranguren, G. (1994). Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology, 56(1), 63–66.

Santos, C. M. D. C., Pimenta, C. A. D. M., & Nobre, M. R. C. (2007). The PICO strategy for the research question construction and evidence search. Revista latino-americana de enfermagem, 15(3), 508-511.

Sellers, J. D., Block, F. E., & McDonald, J. S. (1989). Anesthetic management of labor in a patient with dextrocardia, congenitally corrected transposition, Wolff-Parkinson-White syndrome, and congestive heart failure. American Journal of Obstetrics and Gynecology, 161(4), 1001–1003.

Sengul, T., Saracoglu, A., Sener, S., & Bezen, O. (2016). The use of sugammadex in a pregnant patient with Wolff-Parkinson-White syndrome. Journal of Clinical Anesthesia, 33, 1–4.

Silva, G., Morais, G. P., Primo, J., Sousa, O., Pereira, E., Ponte, M., Simões, L., & Gama, V. (2013). Aborted sudden cardiac death as first presentation of Wolff–Parkinson–White syndrome. Revista Portuguesa de Cardiologia, 32(4), 325–329.

Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Integrative review: what is it? How to do it? Einstein, 8(1), 102-106.

Szumowski, L., Szufladowicz, E., Orczykowski, M., Bodalski, R., Derejko, P., Przybylski, A., Urbanek, P., Kuśmierczyk, M., Koźluk, E., Sacher, F., Sanders, P., Dangel, J., Haissaguerre, M., & Walczak, F. (2010). Ablation of severe drug-resistant tachyarrhythmia during pregnancy. Journal of Cardiovascular Electrophysiology, 21(8), 877–882.

Taco, E. J. A., Eldredge, C. A., Casa, C. A., Caza, W. C., Chaw, D. C., Burbano, R. P., & Tipan, J. P. (2020). Síndrome de Wolff Parkinson White en paciente gestante. Mediciencias UTA, 4(2), 108.

Tak, T., Berkseth, L., & Malzer, R. (2012). A case of supraventricular tachycardia associated with Wolff-Parkinson-White syndrome and pregnancy. WMJ: Official Publication of the State Medical Society of Wisconsin, 111(5), 228–232.

Takahashi, J., Saheki, Y., & Gardim, S. (2014). O que é PICO e Pico? SlideShare. https://pt.slideshare.net/bibliotecaee/o-que-pico-e-pico

Thanasa, E., & Thanasas, I. (2021). Pregnancy and Wolff -Parkinson -White Syndrome: Case Report. Merit Research Journal of Medicine and Medical Sciences, 9(8), 349–353.

Published

22/12/2022

How to Cite

BRANDÃO, C. de M. F. .; FONSECA NETO, O. J.; ANDRADE, I. C. de O. .; LIMA, C. V. B. Q. de .; SANTOS, J. H. B. .; SILVA, T. S. da .; ERUDILHO, E.; MENDES, Érica de A. S. . Clinical management of pregnant women with Wolff-Parkinson-White Syndrome: diagnosis, treatment and fetal repercussions of interventions. Research, Society and Development, [S. l.], v. 11, n. 17, p. e130111738889, 2022. DOI: 10.33448/rsd-v11i17.38889. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/38889. Acesso em: 22 nov. 2024.

Issue

Section

Health Sciences